Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4652)
All Articles published online
|
Nov 7, 2012 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang HJ, Yao DF, Yao M, Huang H, Wu W, Yan MJ, Yan XD, Chen J. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma. World J Gastroenterol 2012; 18(41): 5897-5904 [PMID: 23139605 DOI: 10.3748/wjg.v18.i41.5897] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i41/5897.htm |
| Number | Citing Articles |
| 1 |
CHONG WANG, YU GUO, JING WANG, ZHIQUN MIN. Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating β-catenin and cyclin D1 expression. Molecular Medicine Reports 2015; 11(3): 2147 doi: 10.3892/mmr.2014.2906
|
| 2 |
Chunbo Zhuang, Pei Wang, Ting Sun, Lei Zheng, Liang Ming. Expression levels and prognostic values of annexins in liver cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.11025
|
| 3 |
Liping Ren, Xianrun Pan, Lin Ning, Di Gong, Jian Huang, Kejun Deng, Lei Xie, Yang Zhang. Construction of a Combined Hypoxia-related Genes Model for Hepatocellular
Carcinoma Prognosis. Current Computer-Aided Drug Design 2023; 19(2): 150 doi: 10.2174/1573409919666221223123610
|
| 4 |
Li-Wei Qiu, Yi-Fei Liu, Xiao-Qing Cao, Yan Wang, Xiao-Hong Cui, Xian Ye, Shuo-Wen Huang, Hong-Jun Xie, Hai-Jian Zhang. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis <i>via</i> the immune microenvironment. World Journal of Gastroenterology 2020; 26(18): 2126-2137 doi: 10.3748/wjg.v26.i18.2126
|
| 5 |
Li Wang, Liuhong Pan, Min Yao, Yin Cai, Zhizhen Dong, Dengfu Yao. Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma. Oncotarget 2106; 7(27): 42150 doi: 10.18632/oncotarget.9892
|
| 6 |
Yu-Shi Wang, He Li, Yang Li, Hongyan Zhu, Ying-Hua Jin. Identification of natural compounds targeting Annexin A2 with an anti-cancer effect. Protein & Cell 2018; 9(6): 568 doi: 10.1007/s13238-018-0513-z
|
| 7 |
Junjian Li, Zhengpin Yu, Qiandong Zhu, Chonglin Tao, Qigang Xu. hsa_circ_102559 Acts as the Sponge of miR-130a-5p to Promote Hepatocellular Carcinoma Progression Through Regulation of ANXA2. Cell Transplantation 2020; 29: 096368972096874 doi: 10.1177/0963689720968748
|
| 8 |
Tian Xiang, Ganglong Yang, Xiaoyu Liu, Yidan Zhou, Zhongxiao Fu, Fangfang Lu, Jianguo Gu, Naoyuki Taniguchi, Zengqi Tan, Xi Chen, Yan Xie, Feng Guan, Xiao-Lian Zhang. Alteration of N -glycan expression profile and glycan pattern of glycoproteins in human hepatoma cells after HCV infection. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(5): 1036 doi: 10.1016/j.bbagen.2017.02.014
|
| 9 |
XIAO-HENG XU, WEI PAN, LI-HUA KANG, HUI FENG, YAN-QIU SONG. Association of annexin A2 with cancer development (Review). Oncology Reports 2015; 33(5): 2121 doi: 10.3892/or.2015.3837
|
| 10 |
Min Yao, Yin Cai, Zhi-Jun Wu, Ping Zhou, Wen-Li Sai, De-Feng Wang, Li Wang, Deng-Fu Yao. Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells. World Journal of Clinical Cases 2022; 10(28): 10017-10030 doi: 10.12998/wjcc.v10.i28.10017
Abstract(379) |
Core Tip(192) |
Full Article(HTML)(1104)
|
Full Article (PDF)-6550K(100)
|
Full Article (Word)-2655K(55)
|
Audio-1816K(2)
|
Peer-Review Report-220K(26)
|
Answering Reviewers-215K(34)
|
Times Cited (0)
|
Total Visits (3879)
|
Open
|
| 11 |
Mekonnen L. Dechassa, Volodymyr Tryndyak, Aline de Conti, Wenming Xiao, Frederick A. Beland, Igor P. Pogribny. Identification of chromatin‐accessible domains in non‐alcoholic steatohepatitis‐derived hepatocellular carcinoma. Molecular Carcinogenesis 2018; 57(8): 978 doi: 10.1002/mc.22818
|
| 12 |
Li Wang, Min Yao, Miao Fang, Wen-Jie Zheng, Zhi-Zhen Dong, Liu-Hong Pan, Hai-Jian Zhang, Deng-Fu Yao. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2018; 17(3): 227 doi: 10.1016/j.hbpd.2018.03.005
|
| 13 |
Sara M. Ø. Solbak, Eldar Abdurakhmanov, Anni Vedeler, U. Helena Danielson. Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA – effects on NS5B catalysis and allosteric inhibition. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0904-4
|
| 14 |
ZHIZHEN DONG, MIN YAO, HAIJIAN ZHANG, LI WANG, HUA HUANG, MEIJUAN YAN, WEI WU, DENGFU YAO. Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis. Oncology Letters 2014; 7(1): 28 doi: 10.3892/ol.2013.1663
|
| 15 |
Maria Christensen, Claus H�gdall, Kirsten Jochumsen, Estrid H�gdall. Annexin A2 and cancer: A systematic review. International Journal of Oncology 2017; doi: 10.3892/ijo.2017.4197
|
| 16 |
Mahesh C. Sharma. Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers. International Journal of Cancer 2019; 144(9): 2074 doi: 10.1002/ijc.31817
|
| 17 |
Huiyu Zhuang, Mingzi Tan, Juanjuan Liu, Xiao Li, Jian Gao, Zhenhua Hu, Lu Deng, Liancheng Zhu, Bei Lin. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them. Tumor Biology 2015; 36(4): 2343 doi: 10.1007/s13277-014-2841-9
|
| 18 |
Ravikiran Tekupalli, Santosh Anand, Sowbhagya Ramachandregowda, Anupama Sindhghatta Kariyappa. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 195 doi: 10.1016/B978-0-323-98807-0.00019-3
|
| 19 |
Nevine El-Abd, Amal Fawzy, Tamer Elbaz, Sherif Hamdy. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma. Tumor Biology 2016; 37(1): 211 doi: 10.1007/s13277-015-3524-x
|
| 20 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
| 21 |
Dalia H. Abou-Elela, Eman Abdel Sameea, Tamer Fakhry. Assessment of the diagnostic role of annexin A2 (ANXA2) and insulin-like growth factor-1 as serum markers for hepatocellular carcinoma. Egyptian Liver Journal 2016; 6(1): 1 doi: 10.1097/01.ELX.0000481901.80695.e7
|
| 22 |
Eman Youssef , Nashwa El-Khouly, Yahia Abdullah Elzahrani , Rehab M. E. Tash , Eman A. Khalifa, Eman S. M. Bayoumy , Mona Khalil, Awatif E. Edreis, Fatma Saffeyeldin Mohamed, Aml E. Abdou, Nora Seliem, Mahmoud Sofy, Sara Fakhrelden, Sohaila M. H. Marmoush, Ghada F. Elmohaseb, Amal A. Elhosary. TGF-1 mRNA, AFP-L3, and Annexin II in the Early and Late Detection of Hepatocellular Carcinoma: The Diagnostic Value. Open Access Macedonian Journal of Medical Sciences 2022; 10(A): 15 doi: 10.3889/oamjms.2022.10814
|
| 23 |
Mohamed K Shaker, Hanzada I Abdel Fattah, Ghada S Sabbour, Iman F Montasser, Sara M Abdelhakam, Eman El Hadidy, Rehab Yousry, Ahmed K El Dorry. Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients. World Journal of Hepatology 2017; 9(9): 469-476 doi: 10.4254/wjh.v9.i9.469
|
| 24 |
Esraa Magdy Abdelraouf, Raghda R.S. Hussein, Ahmed Hassan Shaaban, Hany A.M. El-Sherief, Azza S. Embaby, Seham A. Abd El-Aleem. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression. Life Sciences 2022; 308: 120967 doi: 10.1016/j.lfs.2022.120967
|
| 25 |
Lee D. Gibbs, Kelsey Mansheim, Sayantan Maji, Rajesh Nandy, Cheryl M. Lewis, Jamboor K. Vishwanatha, Pankaj Chaudhary. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients. Cancers 2020; 13(1): 2 doi: 10.3390/cancers13010002
|
| 26 |
Sai Ma, Junping Cheng, Haiyan Wang, Ningling Ding, Feng Zhou, Runing Ji, Li Zhu, Chuanwu Zhu, Yunzhi Pan. A novel regulatory loop miR-101/ANXA2/EGR1 mediates malignant characteristics of liver cancer stem cells. Carcinogenesis 2021; 42(1): 93 doi: 10.1093/carcin/bgaa055
|
| 27 |
Yijie Ning, Yufei Li, Hongqin Wang. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1108167
|
| 28 |
Wu Zhang, Cheng-Guang Zhao, Hong-Yu Sun, Wei-E Zheng, Hua Chen. Expression Characteristics of KAI1 and Vascular Endothelial Growth Factor and Their Diagnostic Value for Hepatocellular Carcinoma. Gut and Liver 2014; 8(5): 536 doi: 10.5009/gnl13331
|
| 29 |
Dipti Chauhan, Ramesh Chandra, Suveen Kumar. Advanced electrochemical nanobiosensor for ultraefficient Annexin A2 biomarker detection: A rapid, label free and minimal invasive approach towards early diagnosis of liver cancer. Materials Letters 2021; 305: 130856 doi: 10.1016/j.matlet.2021.130856
|
| 30 |
Guangzhao Shao, Yao Zhi, Zhongqi Fan, Wei Qiu, Guoyue Lv. Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1171023
|
| 31 |
Yi Shen, Wei Xiong, Qi Gu, Qin Zhang, Jia Yue, Changsong Liu, Duan Wang. Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.654635
|
| 32 |
Jorge Gutiérrez-Cuevas, Silvia Lucano-Landeros, Daniel López-Cifuentes, Arturo Santos, Juan Armendariz-Borunda. Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. Cancers 2022; 15(1): 23 doi: 10.3390/cancers15010023
|
| 33 |
Abd El-Fattah F. Hanno, Fatma M. Abd El-Aziz, Akram A. Deghady, Ehab H. El-Kholy, Aborawy I. Aborawy. Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients. Egyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0004-9
|
| 34 |
Abdullah Zorluoglu. Serum Annexin A2 Levels in Patients with Colon Cancer in Comparison to Healthy Controls and in Relation to Tumor Pathology. Medical Science Monitor 2014; 20: 1801 doi: 10.12659/MSM.892319
|
| 35 |
Haijian Zhang, Min Yao, Wei Wu, Liwei Qiu, Wenli Sai, Junling Yang, Wenjie Zheng, Jianfei Huang, Dengfu Yao. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma. Tumor Biology 2015; 36(12): 9373 doi: 10.1007/s13277-015-3678-6
|